Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for phenylketonuria

R C Eisensmith1, S L Woo

  • 1Department of Cell Biology, Baylor College of Medicine, Houston, TX.

Acta Paediatrica (Oslo, Norway : 1992). Supplement
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.

Gene therapy·2001
Same author

An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.

Molecular therapy : the journal of the American Society of Gene Therapy·2001
Same author

Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication.

The journal of gene medicine·2001
Same author

Molecular correlations in phenylketonuria: mutation patterns and corresponding biochemical and clinical phenotypes in a heterogeneous California population.

Pediatric research·1999
Same author

Haplotypes and mutations of the PAH locus in Egyptian families with PKU.

European journal of human genetics : EJHG·1999
Same author

Engineering the healing of the rabbit medial collateral ligament.

Medical & biological engineering & computing·1998
Same journal

Policy and science in children's health and environment: recommendations from the PINCHE project.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2006
Same journal

Exposure to multiple environmental agents and their effect.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2006
Same journal

Air pollution: a threat to the health of our children.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2006
Same journal

Environmental tobacco smoke exposure and children's health.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2006
Same journal

Ionizing radiation and children's health: conclusions.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2006
Same journal

Adverse health effects of children's exposure to pesticides: what do we really know and what can be done about it.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2006
See all related articles

Somatic gene therapy shows promise for treating phenylketonuria (PKU). Adenoviral vectors successfully corrected PKU in mice, normalizing phenylalanine levels, though the effect was temporary.

Area of Science:

  • Medical Genetics
  • Hepatology
  • Gene Therapy

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder.
  • It results from a deficiency in hepatic phenylalanine hydroxylase (PAH).
  • Somatic gene therapy is being explored as a potential treatment.

Purpose of the Study:

  • To evaluate different vector systems for PKU gene therapy.
  • To assess the efficacy of adenoviral vectors in correcting PKU in vivo.
  • To investigate the potential of somatic gene therapy for PKU treatment.

Main Methods:

  • Development of three recombinant vector systems: retroviral, DNA/protein complexes, and adenoviral.
  • In vitro transduction of PAH-deficient hepatocytes.
  • In vivo administration of recombinant adenoviral vector into PAH-deficient mice.

Related Experiment Videos

Main Results:

  • Retroviral vectors and DNA/protein complexes showed efficient in vitro transduction but limited in vivo efficiency.
  • Adenoviral vector infusion restored 10-80% of hepatic PAH activity in mice.
  • Serum phenylalanine levels were completely normalized in treated mice, though the effect was transient.

Conclusions:

  • Somatic gene therapy using adenoviral vectors can effectively correct PKU in a mouse model.
  • The transient nature of the correction highlights the need for more persistent vectors.
  • These findings support the feasibility of gene therapy for PKU treatment.